Active Pharmaceutical Ingredients
PHARMACEUTICAL
At AntalGenics we develop novel therapeutic leads, mainly for the treatment of psoriatic pruritus and psoriatic comorbidities, such as arthritis
PHARMACEUTICAL
Our R&D programme is focused on the discovery and development of new molecules to treat chronic painful disorders. Our scientific team has a long-track experience in pain research. With this knowledge, we are currently developing two new molecular entities to provide precise innovative therapies for psoriatic pruritus and osteoarthritic pain

ANTALGENICS OFFERS






